Exact Sciences Corp at Nephron Liquid Biopsy Innovation Symposium (Virtual) Transcript
Good morning. We are joined -- really pleased to be joined by Jeff Elliott, the CFO and COO of Exact Sciences. And hopefully, in a few seconds, there we go. We're also joined by Jake Orville who is the SVP of Pipeline at Exact Sciences.
Questions & Answers
So we just had a great, very nuanced debate on multi-cancer testing. We also talked about Cologuard 2.0 and liquid biopsy there at the end. Maybe just as a kickoff question, we'll start with Jeff. Obviously, the focus today is on liquid biopsy. Just at a high level, can you talk about the learnings from the Cologuard development process? Just what you can -- what you think can be translated over to liquid biopsy? And how you see Cologuard -- how the screening paradigm is going to play out with Cologuard?
Sure. And, Jack, thanks for having us. Really appreciate the time today
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
